AzTrials
AzTrials

Injury of Anterior Cruciate LigamentNCT02933008

Real-time Sensorimotor Feedback for Injury Prevention Assessed in Virtual Reality

A study testing aNMT Biofeedback and Neuromuscular Training in people with Injury of Anterior Cruciate Ligament, run by Emory University at 2 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Traumatic, debilitating anterior cruciate ligament (ACL) injuries occur at a 2 to 10-fold greater rate in female than male athletes. Consequently, there is a larger population of females that endure significant pain, functional limitations, and radiographic signs of knee osteoarthritis (OA) within 12 to 20 years… Read more about this study

Who is it for?
Ages 12 to 18 years, women onlyHealthy volunteers can take part
Conditions the study is for
Injury of Anterior Cruciate Ligament
What is being tested?
aNMT Biofeedback and Neuromuscular Training
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
420 participants
Where
2 sitesUnited States
Study dates
Dec 2016to 30 May 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 to 18 years
  • Women only
  • Healthy volunteers accepted
  • Child, Adult

Who may be able to join

  • intend to participate on an organized competitive sports team (volleyball, soccer, or basketball)
  • be physically able to participate in their sport and complete the testing procedures at the time of study enrollment

Who cannot join

  • none

Trial locations and contacts

2 sites in 1 country.

United States2 sites
  • Cincinnati Childrens Hospital Medical Center

    Cincinnati, Ohio, 45229

  • Emory Healthcare Sports Performance And Research Center (SPARC)

    Flowery Branch, Georgia, 30542

Other trials in United States

About this study

Traumatic, debilitating anterior cruciate ligament (ACL) injuries occur at a 2 to 10-fold greater rate in female than male athletes. Consequently, there is a larger population of females that endure significant pain, functional limitations, and radiographic signs of knee osteoarthritis (OA) within 12 to 20 years following injury. To reduce the burden of OA, The National Public Health Agenda for Osteoarthritis recommends expanding and refining evidence-based prevention of ACL injury. Specialized training that targets modifiable risk factors shows statistical efficacy in high-risk athletes; however, clinically meaningful reduction of risk has not been achieved. A critical barrier that limits successful training outcomes is the requirement of qualified instructors to deliver personalized, intuitive, and accessible feedback to young athletes. Thus, a key gap in knowledge is how to efficiently deliver objective, effective feedback during training for injury prevention. The investigators long-term goal is to reduce ACL injuries and the subsequent sequela in young female athletes. The overall objective of this proposal is to implement and test innovative augmented neuromuscular training (aNMT) techniques to enhance sensorimotor learning and reduce biomechanical risk factors for ACL injury. The rationale that underlies this proposal is that, after completion, the investigators will be equipped to more effectively deliver biofeedback and decelerate the trend of increasing ACL injury rates in female athletes. This contribution will be significant for the reduction of the long-term sequel following ACL injury in young females.

Read the detailed description

Augmented neuromuscular training (aNMT) integrates biomechanical screening with state-of-the-art augmented reality headsets to display real-time feedback that maps complex biomechanical variables onto simple visual feedback stimuli that athletes "control" via their own movements. The central hypothesis is that aNMT biofeedback will improve joint mechanics in evidence-based measures collected in realistic, sport-specific virtual reality scenarios. Specifically, the purpose of this investigation is to determine the efficacy of aNMT biofeedback to improve high-risk landing mechanics both in a laboratory task and during sport-specific scenarios. Based on the investigator's preliminary data, the investigators hypothesize that aNMT biofeedback will produce greater improvements in localized joint mechanics compared to neuromuscular training that incorporates sham feedback during the drop vertical jump (DVJ) task. In the secondary Aim, the investigators hypothesize aNMT will produce improved localized joint mechanics and global injury risk techniques during sport-specific maneuvers assessed in immersive virtual environments compared to the sham feedback. The expected outcomes will support increased efficiency and enhanced efficacy of feedback for personalized and targeted injury prevention training. The positive impact will be the improvement of injury risk mechanics and the potential to reduce injury on the field of play. A randomized, repeated-measures design will be used to test the two hypotheses for Aim 1: First, that aNMT will produce greater improvements in localized joint mechanics compared to the sham feedback group during the DVJ task; second, based on the preliminary data the investigators expect that innovative aNMT will lead to graduated joint improvements and reduced global injury risk mechanics that will exceed the overall task transferred reductions in high risk biomechanics following 12 real-time biofeedback training sessions. Previously described techniques will be used to measure biomechanical risk factors during a DVJ task performed at the beginning and end of the 6-week pre-competition training period. Athletes will be randomized into one of two groups: 1) aNMT biofeedback or (2) sham (augmented reality glasses with a stimulus that will provide exercise repetition count). Each athlete, as well as the statisticians, will be blinded to the intervention. All athletes will receive 12 training sessions over a 6-week period during their pre-competition season and each of the groups will have longitudinal assessment of biomechanical outcome measures captured at each biofeedback session. All participants will complete pre-training testing, 6 weeks of intervention, post-training testing, and post-season testing.

Being tested
aNMT Biofeedback, Sham Biofeedback, Neuromuscular Training
Keywords
ACL, biofeedback, injury prevention, virtual reality
Medical subject headings
Anterior Cruciate Ligament Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • aNMT BiofeedbackOther

    aNMT utilizes well-established visual feedback strategies to promote efficient, rapid and robust learning of complex movements. Athletes can discover how to move to create the desired feedback, even without explicit, conscious knowledge of how their movements relate to the visual pattern. aNMT biofeedback is created by calculating kinematic and kinetic data in real-time from the athlete's own movements. These values determine real-time transformations of the stimulus shape the athlete views via augmented-reality (AR) glasses during movement performance. The athlete's task is to move so as to create ("animate") a particular stimulus shape that corresponds to desired values of the biomechanical parameters targeted by the intervention.

  • Sham BiofeedbackOther

    Sham biofeedback provides a similar phenomenological experience to aNMT biofeedback for athletes-both groups experience a shape that changes with their movements-but the sham biofeedback will not provide usable information to modify movement parameters during critical movement phases.

  • Neuromuscular TrainingOther

    Participants will complete a 12-session, pre-season training program, over 6 weeks.

Study groups in NCT02933008
Study groupRoleWhat they receive
aNMT BiofeedbackExperimentalParticipants randomized to receive a neuromuscular training intervention that incorporates biofeedback training.
Receives: Other: aNMT Biofeedback; Other: Neuromuscular Training
Sham BiofeedbackSham comparatorParticipants randomized to receive a neuromuscular training intervention with sham feedback training.
Receives: Other: Sham Biofeedback; Other: Neuromuscular Training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Lateral Trunk Flexion

    Lateral trunk flexion during the vertical drop task will be compared between study arms. Optimal lateral trunk flexion is 0°.

    Measured: Baseline (pre-training testing), Week 6 (post-training testing)

  2. Change in Knee to Hip Sagittal Plane Moment Ratio

    Knee to hip sagittal plane moment ratio during the vertical drop task will be compared between study arms. Optimal knee to hip sagittal plane ratio is < 1.

    Measured: Baseline (pre-training testing), Week 6 (post-training testing)

  3. Change in Knee Abduction Moment

    Knee abduction moment during the vertical drop task will be compared between study arms. Optimal knee abduction moment is ≤ 0 newton meter (Nm).

    Measured: Baseline (pre-training testing), Week 6 (post-training testing)

  4. Change in Foot Placement

    Foot placement during the vertical drop task will be compared between study arms. Optimal foot placement is 1:1 ratio to hip width.

    Measured: Baseline (pre-training testing), Week 6 (post-training testing)

  5. Change in Vertical Ground Reaction Force (VGRF) Ratio

    VGRF during the vertical drop task will be compared between study arms. Optimal VGRF ratio is 1:1 ratio between limbs.

    Measured: Baseline (pre-training testing), Week 6 (post-training testing)

Secondary outcomes (5)
  1. Change in Post-training Lateral Trunk Flexion

    Retention of effects of the intervention is assessed with lateral trunk flexion during the vertical drop task will be compared between study arms. Optimal lateral trunk flexion is 0°.environments compared to the sham feedback. The expected outcomes will support increased efficiency and enhanced efficacy of feedback for personalized and targeted injury prevention training.

    Measured: Week 6 (post-training testing), up to Month 11 (post-season testing)

  2. Change in Post-training Knee to Hip Sagittal Plane Moment Ratio

    Retention of effects of the intervention is assessed with knee to hip sagittal plane moment ratio during the vertical drop task will be compared between study arms. Optimal knee to hip sagittal plane ratio is < 1.

    Measured: Week 6 (post-training testing), up to Month 11 (post-season testing)

  3. Change in Post-training Knee Abduction Moment

    Retention of effects of the intervention is assessed with knee abduction moment during the vertical drop task will be compared between study arms. Optimal knee abduction moment is ≤ 0 newton meter (Nm).

    Measured: Week 6 (post-training testing), up to Month 11 (post-season testing)

  4. Change in Post-training Foot Placement

    Retention of effects of the intervention is assessed with foot placement during the vertical drop task will be compared between study arms. Optimal foot placement is 1:1 ratio to hip width.

    Measured: Week 6 (post-training testing), up to Month 11 (post-season testing)

  5. Change in Post-training Vertical Ground Reaction Force (VGRF) Ratio

    Retention of effects of the intervention is assessed with VGRF during the vertical drop task will be compared between study arms. Optimal VGRF ratio is 1:1 ratio between limbs.

    Measured: Week 6 (post-training testing), up to Month 11 (post-season testing)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Oct 2016 (estimated)
  2. Study startDec 2016
  3. Primary completion9 May 2022
  4. Study completion30 May 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
420 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02933008
Sponsor's protocol ID
STUDY00001770
Other IDs
5U01AR067997, 2014-2946
Status last verified
Sep 2024
First submitted
7 Mar 2016
Last updated
19 Sep 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: While study results will be published, individual subject data will not be shared with other researchers.

Questions about this trial

What is this clinical trial studying?

A study testing aNMT Biofeedback and Neuromuscular Training in people with Injury of Anterior Cruciate Ligament, run by Emory University at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Sep 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Lateral Trunk Flexion (time frame: Baseline (pre-training testing), Week 6 (post-training testing)). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Sep 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in